The expression of hepcidin is significantly upregulated in patients with malignant tumors, and it has been found that tumors that synthesize hepcidin can reduce the expression of membrane iron transporters in an autocrine manner, thereby limiting iron discharge from tumor cells and promoting tumor growth by increasing iron content in tumor cells (Sacco et al., 2021). The gene discussed is HAMP; the disease is cancer.